Skip to main content
Caplight Logo









CureAble

CureAble

Private
NoidaHealthcare & Life Scienceshttps://cureable.in

Last Round

Pre Seed

Feb 19, 2025

Total Funding Raised

$230,000

Company Overview

CureAble operates in Healthcare & Life Sciences and is based in Noida. Its latest recorded funding round was a Pre Seed round in February 2025.

CureAble is a healthcare startup that provides personalized therapy services and developmental support for children with special needs.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Telemedicine

Business Model

B2C

Customer Profile

Services & Consulting

AI Layer

Non-AI

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

CureAble Comparables

Compare CureAble with similar companies based on industry and business-model similarity.

CureAble comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
FyndHealth
87%
Continua Kids
86%
Mango Town
86%
Book a demo to see all comparables

For institutional investors. Book with your work email.

CureAble Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre SeedFeb 19, 2025
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Key People

Founding team and executive leadership

Krish Singh

Co-founder and CEO

Founding Team

For institutional investors. Book with your work email.

CureAble Investors

Notable investors and investment history

CureAble investors
InvestorRounds
Brahma TankPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 2, 2026

    Open job postings surged to 39 roles (103% of headcount, 2.9x the trailing average)

  • Oct 16, 2025

    Grew 22% QoQ, from 23 to 28 employees.

Book a demo to see all signals

For institutional investors. Book with your work email.

CureAble Filings

Explore SEC and related filing metadata, where available.

CureAble filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about CureAble's valuation, stock price, and market status.

Is CureAble a public or private company?

CureAble is a private company.

What is the current stock price of CureAble?

CureAble is a private company, so its shares have no public market price. Caplight tracks CureAble's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is CureAble worth (valuation)?

Valuation information for CureAble is not publicly available.

Can I buy CureAble stock?

CureAble shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was CureAble's last funding round?

CureAble's most recent funding round was Pre Seed on February 19, 2025.

Who are the main investors in CureAble?

Key investors in CureAble include Brahma Tank.

Will CureAble IPO soon?

No public IPO plans have been announced for CureAble.

How can I track CureAble secondary market activity?

Caplight tracks bids, offers, and trades in CureAble's shares on secondary markets.

Firmographic Details

HeadquartersNoida
Employee Range38
Year Founded2023
Last FundingFeb 19, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?